NCT07209345View on ClinicalTrials.gov

Pre-emptive Scalp Infiltration With Low-dose Flurbiprofen and Ropivacaine for Postoperative Analgesia After Craniotomy

NANot yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

October 15, 2026

Study Completion Date

October 15, 2026

Conditions
Post-craniotomyPain
Interventions
DRUG

FA+Ropivacaine

0.5 mL FA (50 mg; by Beijing Taide Pharmaceutical Co., Ltd) and 15 mL of 1% ropivacaine (Nai Le Pin 10mg/mL; by AstraZeneca AB, Sweden) diluted to a total volume of 30 mL in normal saline

DRUG

Normal (0.9%) saline

Control group:

DRUG

Ropivacaine

15 mL of 1% ropivacaine diluted to a total volume of 30 mL in normal saline

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER

NCT07209345 - Pre-emptive Scalp Infiltration With Low-dose Flurbiprofen and Ropivacaine for Postoperative Analgesia After Craniotomy | Biotech Hunter | Biotech Hunter